Pruritus Therapeutics Market
According to Intent Market Research, the Pruritus Therapeutics Market is expected to grow from USD 972.3 million in 2024-e at a CAGR of 12.3% to touch USD 1,947.6 million by 2030. The Pruritus Therapeutics Market is dominated by key players such as, Eli Lilly and Company, AbbVie Inc., Novartis International AG, GlaxoSmithKline plc, and Johnson & Johnson.